News

Suppliers face £130m fine after appeal against CMA finding on hydrocortisone pricing fails
Auden McKenzie and Actavis UK, which raised prices for hydrocortisone tablets by over 10,000 per cent over a decade, have had their appeal against a Competition and Markets Authority finding of excessive pricing rejected.
19 Sep 2023 , 1 Min Article